Completed PHASE4 INTERVENTIONAL 2-arm NCT04931433

Intravenous Lignocaine as an Analgesic Adjunct in Adolescent Idiopathic Scoliosis Surgery (IGNITE-AIS)

Intravenous Lignocaine as an Analgesic Adjunct in Adolescent Idiopathic Scoliosis Surgery (IGNITE-AIS Study)

Sponsor: University of Malaya

Conditions Adolescent Idiopathic Scoliosis Analgesia

Updated 4 times since 2021 Last updated: Jun 5, 2024 Started: Dec 24, 2020 Primary completion: Mar 31, 2022 Completion: Sep 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Adolescent Idiopathic Scoliosis and Analgesia and is currently completed. University of Malaya leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jul 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Sep 2021 — Jul 2023 [monthly]

Recruiting PHASE4

First recorded

Dec 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Malaya

Data source: University of Malaya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pantai Valley, Malaysia